MARKET OVERVIEW – HOW IS THE GLOBAL NICOTINAMIDE MARKET GROWING?
According to TechSci Research report, The Global Nicotinamide Market will grow from USD 717.21 Million in 2025 to USD 1063.13 Million by 2031, registering a CAGR of about 6.78% over the forecast period. Nicotinamide is the amide form of Vitamin B3 and a critical water‑soluble nutrient used extensively in pharmaceutical formulations, cosmetic applications and animal nutrition.
Market growth is fundamentally driven by the rising prevalence of dermatological conditions that require effective skin‑barrier treatments, the robust expansion of the global livestock sector that needs high‑performance feed additives for disease prevention, and growing consumer focus on preventative healthcare that boosts demand for vitamin‑based dietary supplements.
KEY FIGURES – WHAT ARE THE CORE FORECAST METRICS?
Forecast Period: 2027–2031
Market Size (2025): USD 717.21 Million
Market Size (2031): USD 1063.13 Million
CAGR (2026–2031): 6.78%
Fastest Growing Segment: Pharmaceuticals
Largest Regional Market: Asia Pacific
KEY MARKET DRIVERS – WHAT IS FUELING DEMAND FOR NICOTINAMIDE?
How Is Cosmeceutical and Anti‑Aging Skincare Demand Reshaping the Market?
The surging demand for cosmeceuticals and anti‑aging skincare is reshaping the Global Nicotinamide Market, as the ingredient is increasingly valued for its ability to enhance skin‑barrier function and reduce hyperpigmentation. Cosmetic manufacturers are aggressively incorporating high‑purity Vitamin B3 into serums and creams to serve a well‑informed consumer base that seeks multifunctional active ingredients.
High levels of online interest in niacinamide as a skincare ingredient underscore its pivotal role in modern beauty routines alongside established actives such as retinol. This sustained popularity is compelling chemical suppliers to expand production capacities for cosmetic‑grade nicotinamide that meets strict purity and safety requirements.
How Is the Animal‑Feed Industry Supporting Industrial Consumption?
At the same time, market growth is supported by expansion of the animal‑feed industry, driven by global livestock production where nicotinamide is an essential additive for metabolic health and disease prevention in poultry and swine. As global meat consumption rises, industrial demand for feed‑grade vitamins intensifies to ensure herd or flock performance and food‑supply security.
Recent increases in worldwide feed tonnage directly correlate with higher Vitamin B3 procurement, while leading animal‑nutrition businesses reporting solid organic sales growth highlight the robust commercial momentum within the livestock nutrition ecosystem.
KEY MARKET CHALLENGES – WHAT IS HOLDING BACK GROWTH?
Why Does Geographic Concentration of Manufacturing Create Supply‑Chain Risk?
The Global Nicotinamide Market faces a significant impediment to growth from the intense geographic concentration of manufacturing capacity. Reliance on a limited number of regional production hubs creates a fragile supply‑chain structure in which localized events—such as regulatory changes, plant outages or logistics disruptions—can trigger widespread availability issues.
Downstream industries are therefore exposed to price volatility and inconsistent raw‑material flows, which complicate long‑term expansion plans and undermine the stability needed for sustained market development. Trade data showing that large portions of global Vitamin B3 supply originate from a single exporting country illustrate how global supply security remains tethered to a narrow production base.
KEY MARKET TRENDS – HOW IS PRODUCTION AND DEMAND EVOLVING?
How Is Green Biomanufacturing Transforming Nicotinamide Production?
Manufacturers are increasingly shifting from traditional chemical synthesis to green biomanufacturing processes, employing chemo‑enzymatic routes and microbial fermentation to lower environmental impact and strengthen regulatory compliance. This trend is distinct from routine supply‑chain optimization, focusing instead on reducing the carbon footprint of production to satisfy sustainability‑conscious customers and investors.
Major industry players are formalizing these commitments through validation frameworks, such as science‑based climate targets, that require substantial reductions in Scope 1 and 2 greenhouse‑gas emissions by 2030. These initiatives set new benchmarks for eco‑efficient nicotinamide manufacturing and differentiate suppliers on environmental performance as well as quality and cost.
Why Is Male Grooming Emerging as a New Demand Channel?
Simultaneously, the market is seeing distinct expansion into the male grooming segment, driven by a demographic shift in which men actively seek functional skincare ingredients like nicotinamide for its non‑greasy, barrier‑strengthening properties. Unlike broader cosmeceutical demand centered on general anti‑aging, this trend is specific to male consumers using digital platforms to learn about ingredient efficacy and product selection.
Growth in searches for niacinamide serums among male users on social media and inspiration platforms confirms the ingredient’s rising status as a staple in men’s personal‑care routines and encourages brands to develop targeted formulations featuring nicotinamide as a lead active.
SEGMENTAL INSIGHTS – WHICH APPLICATION SEGMENT IS GROWING FASTEST?
Why Is the Pharmaceuticals Segment Expanding Most Rapidly?
The pharmaceuticals segment is the fastest‑growing category within the Global Nicotinamide Market. This expansion is driven by increasing use of Vitamin B3 in therapeutic treatments for dermatological disorders, such as acne and inflammatory conditions, and for severe vitamin‑deficiency diseases like pellagra that require clinical‑grade supplementation.
In addition, ongoing research into nicotinamide’s role in managing metabolic disorders and certain oncological indications is broadening its medicinal scope. Continued validation from regulatory authorities regarding therapeutic usage supports a strong safety profile and accelerates adoption across both prescription and over‑the‑counter healthcare products.
REGIONAL INSIGHTS – WHY DOES ASIA PACIFIC LEAD THE NICOTINAMIDE MARKET?
How Is Asia Pacific Maintaining Its Dominant Position?
Asia Pacific holds a dominant position in the Global Nicotinamide Market, reflecting its dual role as a major manufacturing base and a fast‑growing consumption center. The region benefits from extensive production facilities in China and India that provide cost‑effective raw material supply to global customers.
Market growth is further reinforced by a robust personal‑care industry, especially in South Korea and Japan, where nicotinamide is a staple ingredient in functional skincare and brightening formulations. Strong adherence to local quality and safety standards helps ensure product reliability, reinforcing Asia Pacific’s leadership in both volume and innovation.
RECENT DEVELOPMENTS – WHAT STRATEGIC MOVES ARE SHAPING THE MARKET?
How Are Clinical Evidence, Capacity Additions and Portfolio Shifts Influencing the Landscape?
In November 2025, Niagen Bioscience, Inc. (formerly ChromaDex Corp.) reported results from a randomized controlled clinical trial on its patented nicotinamide riboside ingredient in Long‑COVID patients, showing increased NAD⁺ levels and improvements in executive function, fatigue, depression and sleep quality, thereby extending Vitamin B3 derivatives into complex post‑viral therapeutics.
In March 2025, dsm‑firmenich released in vivo study findings demonstrating that its Niacinamide PC ingredient significantly improves post‑menopausal skin by strengthening the barrier and reducing collagen degradation markers while boosting ceramide levels, positioning nicotinamide as a key active for menopause‑focused skincare.
In January 2025, Jubilant Ingrevia Limited commissioned a new cGMP‑compliant Niacinamide facility in Bharuch, Gujarat, with 5,000‑metric‑ton capacity, dedicated to nutraceutical and dietary‑active ingredients for global food, nutrition, cosmetics and infant‑nutrition markets, including higher‑margin human‑grade Vitamin B3.
In December 2024, Lonza announced a strategic “One Lonza” restructuring, deciding to exit its Capsules & Health Ingredients business—historically including Vitamin B3—to focus exclusively on CDMO activities, signaling portfolio realignment and potential shifts in global niacinamide supply.
KEY MARKET PLAYERS – WHO ARE THE MAJOR COMPANIES IN THE GLOBAL NICOTINAMIDE MARKET?
Leading companies in the Global Nicotinamide Market include:
Nebula Health Care | Suchem Laboratory | Western Drugs Limited | Roopa Industries Limited | S.V. Labs Pvt. Ltd. | Veer Chemie & Aromatics Pvt. Ltd. | Optimus Drugs Pvt. Ltd. | NIGAM FINECHEM Pvt. Ltd. | Ishita Drugs & Industries Ltd | Anhui Redpont Biotechnology Co., Ltd
10 BENEFITS OF THIS GLOBAL NICOTINAMIDE MARKET STUDY
Provides clear visibility into market size, CAGR and forecast up to 2031.
Explains how cosmeceuticals and anti‑aging skincare drive demand for cosmetic‑grade nicotinamide.
Highlights the role of animal‑feed and livestock growth in sustaining feed‑grade Vitamin B3 consumption.
Details how geographic concentration of manufacturing creates supply‑chain risk and price volatility.
Describes the shift toward green biomanufacturing and emissions‑reduction commitments in Vitamin B3 production.
Shows how male grooming and targeted skincare trends open new demand channels for niacinamide‑based products.
Clarifies why the pharmaceuticals segment is the fastest‑growing application area.
Provides regional insight into Asia Pacific’s dominance through manufacturing hubs and strong personal‑care demand.
Maps recent clinical trials, capacity expansions and portfolio exits that reshape capabilities and application scope.
Supports strategic planning around supply‑risk mitigation, sustainability positioning, product‑portfolio focus and regional market expansion.
Frequently Asked Questions (FAQs) – TechSci Research | Global Nicotinamide Market
Q1: What is the expected size and growth rate of the Global Nicotinamide Market?
The Global Nicotinamide Market is projected to grow from USD 717.21 Million in 2025 to about USD 1063.13 Million by 2031, at a CAGR of around 6.78% over 2026–2031.
Q2: Which segment is growing fastest in the Nicotinamide market?
The Pharmaceuticals segment is the fastest‑growing category, driven by rising use in dermatology, deficiency management and emerging metabolic and oncological indications.
Q3: Why is Asia Pacific the largest regional market for Nicotinamide?
Asia Pacific leads due to its strong manufacturing base in China and India, combined with robust personal‑care demand in countries such as South Korea and Japan and adherence to quality standards that support global supply.
Q4: What are the main challenges facing the Global Nicotinamide Market?
Key challenges include heavy dependence on a limited number of production hubs, exposure to regulatory and logistics shocks, and resulting instability in prices and raw‑material availability for downstream users.
Q5: How are sustainability and new consumer segments influencing the Nicotinamide market?
Manufacturers are adopting green bioprocesses and climate‑aligned goals, while brands are leveraging nicotinamide in men’s grooming, menopause‑focused skincare and advanced NAD⁺‑related therapeutics to tap into new, high‑value segments.